MktsMarkets

Protagonist Therapeutics, Inc.
NASDAQ: PTGXKey statistics
PTGX News
Stories mentioning PTGX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 46,739 | 46,358 | 40,003 | 37,036 | 35,893 | 34,904 | 35,970 | 33,520 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 60,016 | 57,792 | 51,133 | 47,587 | 47,631 | 43,858 | 46,128 | 42,960 |
| Operating Income (Loss) | (3,648) | (50,355) | (46,421) | (42,041) | (19,310) | 126,780 | (41,453) | (38,793) |
| Interest Income | 5,876 | 6,761 | 7,049 | 7,406 | 7,573 | 6,853 | 7,682 | 7,404 |
| Interest Expense | ||||||||
| Other Expense | 53.00 | (124.00) | 33.00 | 36.00 | 82.00 | 31.00 | 141.00 | 97.00 |
| Pretax Income | 2,281 | (43,718) | (39,339) | (34,599) | (11,655) | 133,664 | (33,630) | (31,292) |
| Tax Provision | (1,502) | 666.00 | 0.00 | 172.00 | 0.00 | 1,990 | (420.00) | (676.00) |
| Net Income (Loss) | 3,783 | (44,384) | (39,339) | (34,771) | (11,655) | 131,674 | (33,210) | (30,616) |
| Earnings Per Share (Basic) | 0.06 | (0.70) | (0.62) | (0.55) | (0.19) | 2.14 | (0.54) | (0.50) |
| Earnings Per Share (Diluted) | 0.05 | (0.70) | (0.62) | (0.55) | (0.19) | 2.02 | (0.54) | (0.50) |
| Weighted Average Shares Outstanding (Basic) | 65,088 | 63,573 | 63,772 | 63,511 | 62,964 | 61,567 | 61,768 | 61,305 |
| Weighted Average Shares Outstanding (Diluted) | 70,493 | 63,573 | 63,772 | 63,511 | 62,964 | 65,078 | 61,768 | 61,305 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PTGX
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is a stock listed on the Nasdaq Stock Market under the ticker symbol PTGX. It last traded at $134.97 (Nov 9, 2026, 10:00 AM ET), up 2.2% on the day. That gives Protagonist Therapeutics a market capitalisation of $8.6B and a price-to-earnings ratio of 104.0.
Over the past 52 weeks PTGX has traded between $76.70 and $160.81.
Net income for the quarter ended Mar 31, 2026 was $3.8M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | $3.8M |
| Dec 31, 2025 | — | -$44.4M |
| Sep 30, 2025 | — | -$39.3M |
| Jun 30, 2025 | — | -$34.8M |
From Protagonist Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…